White Paper:
Looking Ahead: Neurology Clinical Trial Landscape in 2023

Globally, neurological disorders are the leading cause of disability and the second leading cause of death. Neurological disorders with the highest burden of disease in the US include stroke, Alzheimer’s disease (AD), other dementias, and migraines. Stroke is a leading cause of death and a major cause of serious disability for adults in the US, where more than 795,000 people suffer a stroke each year.

This white paper will cover:

  • Growth in neurological disorder drugs market
  • Growth in demand for neurology CRO services
  • Challenges and opportunities for neurology VCTs